Edesa Biotech appoints Peter J. Weiler as the new Chief Financial Officer, effective May 2025, succeeding Stephen Lemieux. Weiler brings extensive experience in corporate finance and strategic development from Exzell…
The biotech sector is rebounding in 2024 due to scientific breakthroughs and positive market conditions. Kodiak Sciences Inc. (NASDAQ:KOD) is advancing its Antibody Biopolymer Conjugate (ABC) platform to treat chronic…
DarwinHealth has been recognized as one of the World's Most Innovative Companies for 2025 by Fast Company, highlighting their pivotal role in advancing cancer treatment. The company leverages the powerful…
Asia's financial landscape presents both challenges and opportunities amid global economic uncertainties. Penny stocks offer high risk and high reward, acting as potential wildcards for investors. Yangzijiang Shipbuilding (Holdings) shows…
Vertex Pharmaceuticals and Moderna represent long-term investment opportunities in the biotech sector. Vertex Pharmaceuticals recently achieved FDA approval for Journavx, a non-opioid pain medication, amid the opioid crisis. Vertex continues…
Valerio Therapeutics has suspended all clinical trials due to significant financial challenges. The company is pivoting towards early-stage projects while developing a single-chain antibody platform. Financial resources are projected to…
Aurion Biotech plans to IPO on the New York Stock Exchange under the ticker "AURN." Challenges include a lawsuit from Alcon Research alleging violations of shareholder rights. Aurion countersued, accusing…
Jiangsu Hengrui Pharmaceuticals Sets Global Aspirations In a recent presentation at the prestigious J.P. Morgan Healthcare Conference, Jiangsu Hengrui Pharmaceuticals showcased its ambitious plans to expand its influence beyond China.…
Important Notice for TipRanks Users Recently, certain users of TipRanks have encountered account restrictions due to unusual activity patterns. Such activity may include exceeding 80 views on a specific page…